UN says $600 mln needed to tackle Ebola as deaths top 1,900

By REUTERS
September 4, 2014 03:06
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

WASHINGTON/CONAKRY - The United Nations said $600 million in supplies would be needed to fight West Africa's Ebola outbreak, as the death toll from the worst ever epidemic of the virus topped 1,900 and Guinea warned it had penetrated a new part of the country.

The pace of the infection has accelerated, and there were close to 400 deaths in the past week, officials said on Wednesday. It was first detected deep in the forests of southeastern Guinea in March.

The hemorrhagic fever has spread to Liberia, Sierra Leone, Guinea, Nigeria, and Senegal, and has killed more people than all outbreaks since Ebola was first uncovered in 1976. There are no approved Ebola vaccines or treatments.

An experimental Ebola vaccine that Canada said it would give to the World Health Organization for use in Africa was as of Wednesday still in the lab that developed it as officials are puzzled over how to transport it.

Ottawa said on Aug. 12 that it would donate between 800 and 1,000 doses of the vaccine, being held at Canada's National Microbiology Laboratory in Winnipeg.

"We are now working with the WHO to address complex regulatory, logistical and ethical issues so that the vaccine can be safely and ethically deployed as rapidly as possible," Health Canada spokesman Sean Upton said in a statement.

"For example, the logistics surrounding the safe delivery of the vaccine are complicated." Upton said one of the challenges was keeping the vaccine cool enough to remain potent.

Human safety trials are due to begin this week on a vaccine from GlaxoSmithKline Plc and later this year on one from NewLink Genetics Corp.

Related Content

Breaking news
July 17, 2018
Trump to meet with members of Congress after summit criticism

By REUTERS